We investigated corticobulbar tract function by recording from the tongue and orofacial muscles and using transcranial magnetic stimulation (TMS) in 30 patients with amyotrophic lateral sclerosis (ALS) in order to improve the diagnostic yield in the detection of subclinical upper motor neuron (UMN) dysfunction. A UMN lesion was assumed when the peripheral conduction time and amplitude of the M-wave were within normal range and either the response to cortical stimulation was absent, or the central conduction time was delayed (>mean ⍣ 2.5 SD). Only two patients showed clinical evidence of UMN involvement in the cranial nerves, while TMS
Introduction
Patients with amyotrophic lateral sclerosis (ALS) may present with pure lower motor neuron (LMN) signs (26% of 326 patients in Dengler et al., 1994) . In these patients upper motor neuron (UMN) dysfunction may not yet be present, or it may be masked by severe muscle weakness and wasting. It is difficult to decide if the administration of riluzole is appropriate at an early stage of the disease (Brooke, 1996) , because these patients do not meet current ALS research criteria (Brooks, 1994) . Assessment of pyramidal tract function using transcranial magnetic stimulation (TMS) is limited in the presence of frequent LMN involvement. Potentials evoked in limb muscles by TMS are less sensitive (47-68%) than clinical signs in demonstrating UMN dysfunction (Claus and Flügel, 1990; Hoberg et al., 1994) . In order to improve the detection of subclinical UMN dysfunction, we investigated corticobulbar tract function to the tongue and orofacial muscles, which are affected early in the course of ALS (Caroscio et al., 1987; Tyler and © Oxford University Press 1998 demonstrated corticobulbar tract dysfunction in the orofacial muscles in 17 patients (57%) and to the tongue in 15 patients (50%). Following recording at both sites, corticobulbar tract dysfunction was confirmed in 21 patients (70%). Twelve out of 13 patients with bulbar symptoms had evidence of additional subclinical corticobulbar tract involvement using TMS. In seven out of 15 patients with isolated limb involvement, subclinical corticobulbar tract dysfunction was demonstrated. Our results indicate the presence of early and, in most cases, subclinical corticobulbar tract involvement in the pathways to the orofacial muscles and tongue in ALS. Shefner, 1991) and may be involved independently of the corticospinal tracts (Davison, 1941; Bonduelle, 1975) .
Methods Patients
We studied 30 consecutive ALS patients with a mean age (Ϯ SD) of 62 Ϯ 11 years (range 31-77 years) and a mean duration of illness of 16 Ϯ 18 months (median 9 months; range 2-72 months) at the time of investigation. All patients gave informed consent to participate in the study, which was approved by the local Ethical Committee/(Landesärztekammer Rheinland-Pfalz).
Recording and stimulating
Compound muscle action potentials (CMAPs) were recorded bilaterally from the orofacial muscles and the tongue. The corticofacial projections were investigated by TMS and recording CMAPs from the buccinator muscles on either side of the face (Fig. 1) . We used pairs of Ag/AgCl-surface disc electrodes embedded, at a separation of 18 mm, in a specially designed fork-shaped metacrylate device which was adapted to the oral vestibulum (Urban et al., 1997a) . The electrodes were in contact with the insides of the cheeks. Slight contraction of the buccinator muscles was achieved by pursing the lips.
The corticolingual projections were examined by TMS and recording CMAPs on either half of the tongue (Fig. 2) . Two pairs of Ag/AgCl-surface disc electrodes at an inter-electrode distance of 18 mm were mounted on a spoon-shaped metacrylate device which was adapted to the oral cavity. The electrodes were placed above the lateral dorsum of the tongue. Slight contraction of the tongue muscles was achieved by pressing the dorsum of the tongue lightly against the mouthpiece. This technique allows selective stimulation of either hemisphere and separate recording from either side of the tongue and the buccinator muscles, as already demonstrated in patients with middle cerebral artery infarction, unilateral hypoglossal nerve section and unilateral facial palsy (Urban et al., 1994 (Urban et al., , 1996b .
The proximal peripheral facial and hypoglossal nerves were stimulated magnetically at their extra-axial intracranial segments. The circular coil was located ipsilaterally and parieto-occipitally, which is appropriate for measuring peripheral conduction time (Muellbacher et al., 1994; Urban et al., 1997a) . For stimulation of the left and right peripheral nerves, respectively, sides 'B' and 'A' of the magnetic coil were viewed from the outside. The distal nerves were also stimulated electrically. All responses were recorded at least twice to ensure reproducibility. A detailed description of the recording technique and normal control data have been published elsewhere (Urban et al., 1994 (Urban et al., , 1996c (Urban et al., , 1997a .
In control subjects, corticolingual fibres are known to project bilaterally from both hemispheres to the hypoglossal nuclei (Urban et al., 1994) . Thus, involvement of the ipsiand contralateral connections can be evaluated separately. Cortico-orofacial fibres project to the contralateral facial subnuclei in 100% and to the ipsilateral subnuclei in 58-67% of control subjects. Thus, only the contralateral connections can be used for evaluating the central pathways reliably (Urban et al., 1996a) .
Filter settings for CMAP-recordings were 20-2000 Hz. A Magstim 200S (Novametrix, Whitland, Dyfed, UK) and a circular coil (mean diameter 9 cm) with a peak magnetic field of 2.0 T were used for TMS stimulation. The centre of the coil was positioned tangentially, 4-6 cm (tongue) and 1-2 cm (buccinator muscle) lateral to Cz, at Cz (upper limbs) and at Fz (lower limbs); for stimulation of the left and right hemispheres, respectively, sides 'A' and 'B' were viewed from above. The stimulation strength was gradually increased stepwise, during slight voluntary muscle contraction, until stable latencies were achieved. The shortest latency and largest amplitude (peak-to-peak) were then measured from four consecutive responses.
A UMN-lesion was assumed when either the cortically evoked response was absent or the central conduction time was delayed (Ͼmean ϩ 2.5 SD) with the peripheral conduction time and amplitude of the M-wave (evoked by supramaximal peripheral nerve stimulation) within normal 
Pϭparesis; F ϭ fibrillations; A ϭ atrophy; PC ϭ pathological crying; D ϭ dysarthria; PB ϭ pseudobulbar signs. For UMN (cranial/ limbs), ϩ ϭ clinical signs of UMN involvement in the cranial nerves and limbs, respectively. The results of TMS indicate the patients with an assumed UMN lesion. For TMS (VII/XII), ϩ ϭ corticobulbar tract involvement using magnetic stimulation, and recordings from the orofacial muscles and tongue, respectively.
limits. The stimulation intensity was increased to 100% of the maximum output of the stimulator before a response was regarded as absent; absence of a potential was defined as no reproducible response in four consecutive trials at a gain of 200 µV/cm (Rösler et al., 1989a) .
Results

Diagnosis of ALS
The diagnosis of ALS was established in all 30 patients, based on clinical findings observed in the course of the disease. However, the majority of the patients were electrophysiologically investigated early in the course of the disease. Initial manifestations of the disease included a bulbar syndrome in 12 patients and involvement of the upper and lower limbs in eight and 10 patients, respectively. At the time of TMS, the clinical examination demonstrated UMN involvement in 15 patients; two of these (Patients 17 and 27) showed isolated pseudobulbar signs (reduced tongue motility with spastic dysarthria and dysphagia, hyperactive jaw reflexes, but no tongue atrophy or fibrillations) while unequivocal signs of UMN lesion to the limbs (cloni, exaggerated deep tendon reflexes, Babinski's sign and/or spasticity) were observed in the other 13 patients (Table 1) .
Signs of bulbar LMN involvement (tongue atrophy and/or fibrillations) were present in 13 of the 30 patients, and were associated with pathological crying in two cases (Patients 3 and 6). LMN involvement in the spinal regions (cervical, thoracic or lumbosacral) was observed clinically (atrophy and fasciculations) and/or electromyographically: in three regions in 12 patients and in two regions in 16 patients. Taking the UMN signs into account, the diagnosis of ALS, according to El Escorial criteria (Brooks, 1994) , was definite in seven, probable in five, and possible in three patients. In all other patients the diagnosis was only suspected at the time of the TMS, but it was confirmed in the further course of the disease.
TMS of the orofacial muscles
In 17 out of 30 patients (57%) TMS demonstrated abnormalities of the contralateral corticofacial projections for at least one side (Table 2) . Isolated peripheral conduction abnormalities were not observed. TMS responses were absent in 22 sides (14 patients) and delayed for eight sides in six patients (Fig. 3) . Clinically, five patients showed slight to moderate bilateral facial paresis which was not definitely identified as being of either nuclear or supranuclear origin (Table 1) .
TMS of the tongue
Three patients with marked tongue atrophy did not tolerate the intra-oral electrode device due to retching. In these patients concentric needle electrodes were used for tongue muscle recordings.
The four individual corticolingual projections (two contralateral, two ipsilateral) were evaluated separately in each patient. Twenty out of 30 patients (66%) showed, with cortical stimulation, abnormalities in at least one projection (Table 2) . In these 20 patients, TMS evoked CMAPs were absent at 57 and delayed for nine corticolingual projections (Fig. 4) . In this group of 20 patients, magnetic stimulation of 14 of the proximal peripheral nerves evoked CMAPs (10 patients) and demonstrated a delayed peripheral conduction time bilaterally in one patient, while electrical stimulation of 29 of the distal peripheral nerves elicited a CMAP (15 patients). UMN involvement was therefore assumed in 15 patients (50%) where electrical peripheral nerve stimulation produced normal results when TMS failed to evoke a response (see Discussion). Fibrillations were observed in 13 patients and tongue atrophy was noted in eight patients. No responses were obtained following cortical TMS stimulation in any of the patients with tongue atrophy, while normal peripheral responses were present on four sides (Patients 5 and 15). In two patients with isolated pseudobulbar signs and normal peripheral responses (Patients 17 and 27), CMAPs were absent following cortical stimulation.
While only two patients (Patients 17 and 27) showed clinical evidence of UMN involvement of the cranial nerves, TMS demonstrated corticobulbar tract dysfunction in the orofacial muscle pathways in 17 patients (57%), and in the tongue pathways in 15 patients (50%). Following recording at both sites, corticobulbar tract dysfunction was confirmed in 21 patients (70%). Twelve out of 13 patients with bulbar symptoms (LMN involvement of the cranial nerves) showed evidence of additional corticobulbar tract involvement when TMS was used, which was not detected clinically. In 15 patients, only the limbs were affected clinically, while the cranial nerves were spared (LMN involvement in seven patients, combined LMN and UMN involvement in eight patients). TMS revealed subclinical corticobulbar tract dysfunction in seven out of the 15 patients (affecting the orofacial muscles in five and the tongue in three patients).
Discussion
ALS is known to involve both UMNs and LMNs. Generalized LMN involvement in ALS can be reliably confirmed using multiple EMG recordings (Lambert and Mulder, 1957 ). An UMN lesion, however, is more difficult to identify because clinical signs may be discrete or masked by severe simultaneous LMN involvement.
Early hypoglossal, trigeminal and facial involvement in the course of ALS has been suggested by investigations using maximum voluntary contraction and movement measure- ments (DePaul et al., 1988) . However, this technique does not differentiate between UMN and LMN lesions. We investigated corticobulbar tract function using TMS to determine whether this would confer higher sensitivity for in assessment of UMN involvement. In ALS, lesions of the facial nucleus are generally restricted to isolated groups of cells (Bonduelle, 1975) with the ventral and lateral parts of the facial nucleus more affected than the dorsal region (Holmes, 1909) . This observation correlates with the clinical finding of a prominent weakness of the perioral muscles, which are represented in the ventrolateral subnucleus of the facial motor nuclear complex (Courville, 1966) . Thus, recordings from the buccinator muscle as performed in our study are especially suitable for this purpose. Due to the predominant perioral weakness, facial paresis can not be conclusively attributed to either a nuclear or supranuclear origin, or to both, by clinical assessment.
Histopathologically, the hypoglossal nucleus is commonly involved in ALS (Bonduelle, 1975) . The clinical equivalents are tongue atrophy and fibrillation. In several pathological studies, the majority of cases show evidence of simultaneous pyramidal tract degeneration even in the presence of predominantly clinical LMN signs (Lawyer and Netsky, 1953; Brownell et al., 1970) . This suggests that bulbar symptoms often include combined UMN and LMN involvement (Leigh and Swash, 1995) .
TMS allows the assessment of central and peripheral motor pathway function. Using TMS of upper limb muscle pathways in ALS, Eisen et al. (1991) , following consideration of all parameters (amplitude, latencies and absence of response), demonstrated that abnormal muscle potentials are found in almost 100% of patients. However, the authors did not differentiate between UMN and LMN involvement. Because TMS-evoked responses and the central conduction time are influenced by central and peripheral conduction properties, we assumed an UMN-lesion only when either the response to cortical stimulation was absent or the central conduction time was delayed (Ͼmean ϩ 2.5 SD) and the peripheral conduction time and amplitude of the M-wave were within normal limits. This definition excludes patients with LMN lesions associated with electroneurographic abnormalities.
In view of the fact that all patients in this study had already undergone an electromyographic investigation for diagnostic purposes, to avoid further discomfort no additional EMGs of the target muscles for TMS were performed. Thus, electromyographic results for most of the target muscles were not available. However, for the purpose of this study, these data are not required, because electromyographic evidence of acute or chronic denervation of single motor units allows no conclusions about the excitability of the motor neuron pool of the muscle following TMS. If the peripheral conduction time and M-wave amplitudes are within the normal range, an LMN lesion cannot be ruled out; there may be a normal peripheral conduction time with preferential degeneration of slow fibres and a normal M-wave amplitude by compensatory reinnervation (Kelly et al., 1990) . However, in this case LMN disorder is an unlikely cause of abnormal TMS responses following cortical stimulation.
Since amplitudes of the cortically evoked responses exhibit considerable inter-individual variation (Amassian et al., 1989; Eisen et al., 1991) , including responses of the tongue and orofacial muscles muscles (Urban et al., 1994; Urban et al., 1996a) , only absent or delayed (Ͼmean ϩ 2.5 SD) responses were considered as abnormal. The TMS-evoked : M-wave amplitude ratio (i.e. the ratio between the maximum amplitude out of four responses to cortical stimulation and the amplitude following supramaximal peripheral nerve stimulation), which is commonly used as an additional parameter to assess pyramidal tract dysfunction (Hess et al., 1987) , is not appropriate in ALS. The M-wave amplitude does not reflect the number of intact lower motoneurones in the early stage of the disease, since collateral reinnervation can compensate for mild to moderate motor unit loss with preservation of Mwave amplitude (Hansen and Ballantyne, 1978) . Furthermore, morphometric studies have demonstrated a preferential degeneration of the larger motoneurones (Tsukagoshi et al., 1979; Sobue et al., 1983) , and H-reflex studies have shown an increased excitability of the remaining motoneurones (Kimura, 1989) . This leads to the assumption that even impaired descending corticomotoneuronal volleys might be sufficient to depolarize the altered LMN pool at the beginning of ALS, thus further reducing the diagnostic sensitivity of the ratio. We have therefore excluded the TMS evoked/Mwave ratio from consideration.
The cortical excitability threshold definition as suggested by the IFCN committee (Rossini et al., 1994) presumes cortical activation only in the relaxed state. This, however, applies to limb muscles but not to facial and tongue muscles. In the cranial muscles, responses to TMS stimulation can only be obtained under slight muscle contraction (Rösler et al., 1989b; Urban et al., 1997a) . Slight contraction of these muscles is also necessary to maintain contact between the tongue surface and the recording device. This factor made cortical excitability threshold measurements unsuitable for our study design.
TMS of the orofacial muscles demonstrated absent or delayed responses following cortical stimulation with normal peripheral responses, consistent with an UMN involvement in 57% of the patients.
TMS responses of the tongue are more difficult to interprete because of some peculiarities associated with peripheral hypoglossal nerve conduction and excitability. Magnetic stimulation of the peripheral hypoglossal nerve in 43 healthy subjects evoked responses in only 65 out of 86 nerves (75.6%) with a peripheral conduction time of 3.6 Ϯ 0.5 ms (Urban et al., 1997c) . The inconsistent occurrence of CMAPs following TMS of the intact hypoglossal nerve has also been reported by others (Muellbacher et al., 1994; Campos et al., 1995) , and it is attributed to the short course of the nerve through the cerebrospinal fluid and its deep position at the base of the skull (Benecke et al., 1988) . Thus, only delay (not absence) of the peripheral hypoglossal nerve TMS response can be considered abnormal. In contrast, electrical stimulation of the hypoglossal nerve at the submandibular level evokes a response in each patient (Redmond and DiBenedetto, 1988) . Due to the limitations of magnetic stimulation of the hypoglossal nerve, UMN involvement was assumed when the response following electrical stimulation was normal and the magnetic evoked responses were absent. On the basis of these criteria, UMN involvement was demonstrated in 15 patients (50%).
In a small number of patients the central conduction time was considerably increased (up to three times the normal mean). Although ALS is not a demyelinating disease, previous studies have demonstrated a frequent increase of the central conduction time to distal limb muscles following transcranial electrical (Hugon et al., 1987; Ingram and Swash, 1987) and magnetic (Schriefer et al., 1989) stimulation. Because TMS excites the largest diameter, fast conducting axons of the corticospinal tract (Rothwell et al., 1987) , the prolongation of central conduction time may result from the predominant degeneration of the large fast-conducting fibres of the corticospinal tract which has been demonstrated morphometrically (Sobue et al., 1987) . The drop out of large corticospinal fibres also results in the spatiotemporal dispersion of the volley impinging on the anterior horn cells which may delay their depolarization.
In the majority of patients, however, responses to TMS were absent in the orofacial muscles (37% of the projections) and the tongue (47.5%), suggesting a more severe degeneration of the corticobulbar fibres. Corresponding to the diffuse and asymmetric loss of corticobulbar and corticospinal fibres observed histopathologically (Swash et al., 1988) , TMS demonstrated an asymmetric and irregular distribution of UMN involvement in most of our patients.
In conclusion, our findings indicate early and in the majority of patients subclinical involvement of the corticobulbar tract to the orofacial muscles and the tongue. This may be especially helpful in investigating patients presenting with purely LMN signs. We therefore propose that TMS to the orofacial muscles and the tongue may contribute to the detection of early and subclinical UMN involvement, enabling earlier diagnosis and treatment of ALS.
